Article
BUB1 Predicts Poor Prognosis and Immune Status in Liver Hepatocellular Carcinoma
2021-10-13
Abstract excerpt
<h4>Background: </h4> Accurate assessment of the tumour immune microenvironment helps develop individualised immunotherapy regimens and screen dominant populations suitable for immunotherapy. Therefore, potential molecular markers were investigated to make an overall assessment of the immune microenvironment status of liver hepatocellular carcinoma (LIHC). <h4>Methods: </h4>: Differentially expressed genes (DEGs)...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bb75ffcc-893d-5f9b-b172-b33f738aedd2
- DOI
- 10.21203/rs.3.rs-936503/v1
